Sigilon Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Sigilon Therapeutics

16/03/2022 21:02

* Sigilon Therapeutics Inc  SGTX.OQ  reported a quarterly
adjusted
loss of 55 cents​​ per share for the quarter ended in December.
The mean expectation of five analysts for the quarter was for a
loss of 56 cents per share.
    * Revenue fell 47% to $1.99 million from a year ago; 
analysts
expected $2.67 million. 
    * Sigilon Therapeutics Inc's reported EPS for the quarter
was a
loss of 55 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sigilon Therapeutics Inc shares had fallen by 51.1% this
quarter.
    * The company reported a quarterly loss of $17.75 million.
    * Wall Street's median 12-month price target for Sigilon
Therapeutics Inc is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 16 at 09:02 p.m.  ​All
figures in US dollars unless otherwise stated